Cellectis (NASDAQ:CLLS) Now Covered by StockNews.com
StockNews.com started coverage on shares of Cellectis (NASDAQ:CLLS – Free Report) in a research note released on Monday morning. The firm issued a sell rating on the biotechnology company’s stock. Cellectis Stock Down 0.5 % Shares of CLLS opened at $1.82 on Monday. The company has a debt-to-equity ratio of 0.39, a quick ratio of […]
More Stories
Ares Capital Co. (NASDAQ:ARCC) Holdings Lowered by Nicholas Hoffman & Company LLC.
Nicholas Hoffman & Company LLC. trimmed its stake in shares of Ares Capital Co. (NASDAQ:ARCC – Free Report) by 2.6%...
Highline Wealth Partners LLC Takes Position in iShares MSCI Mexico ETF (NYSEARCA:EWW)
Highline Wealth Partners LLC acquired a new stake in iShares MSCI Mexico ETF (NYSEARCA:EWW – Free Report) in the third...
SPDR S&P Emerging Asia Pacific ETF (NYSEARCA:GMF) Shares Sold by Nicholas Hoffman & Company LLC.
Nicholas Hoffman & Company LLC. decreased its position in SPDR S&P Emerging Asia Pacific ETF (NYSEARCA:GMF – Free Report) by...
Nicholas Hoffman & Company LLC. Decreases Holdings in AGNC Investment Corp. (NASDAQ:AGNC)
Nicholas Hoffman & Company LLC. reduced its stake in shares of AGNC Investment Corp. (NASDAQ:AGNC – Free Report) by 2.2%...
Herc Holdings Inc. (NYSE:HRI) Shares Sold by Avitas Wealth Management LLC
Avitas Wealth Management LLC reduced its stake in shares of Herc Holdings Inc. (NYSE:HRI – Free Report) by 7.1% in...
MarketWise (MKTW) Scheduled to Post Earnings on Thursday
MarketWise (NASDAQ:MKTW – Get Free Report) will be releasing its earnings data before the market opens on Thursday, November 7th....